FreeAgent a6438a3523ddb7d034f8db0ad1f6b78322880a5c false No description of principal activity 27 January 2025 31 January 2026 162121002025-01-272026-01-31 16212100uk-bus:Director12025-01-272026-01-31 16212100uk-bus:AuditExempt-NoAccountantsReport2025-01-272026-01-31 16212100uk-bus:Micro-entities2025-01-272026-01-31 16212100uk-bus:FullAccounts2025-01-272026-01-31 16212100uk-bus:PrivateLimitedCompanyLtd2025-01-272026-01-31 16212100uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2025-01-272026-01-31 162121002025-01-27 162121002026-01-31 16212100uk-core:CurrentFinancialInstruments2026-01-31 16212100uk-core:Non-currentFinancialInstruments2026-01-31 iso4217:GBP xbrli:pure

SIRI PHARMA CONSULTANCY LTD

Unaudited financial statements for the period from 27 January 2025 to 31 January 2026


Company information

SIRI PHARMA CONSULTANCY LTD is a private company limited by shares, registered in England and Wales, registered number 16212100.

The company's registered office is: 181, Hayling Road, Watford, WD19 7QR, United Kingdom.

Balance Sheet

as at 31 January 2026

12 months to
31 Jan 26
£ £
Current assets 83,384.68
Creditors: amounts falling due within one year (46,033.42)
Net current assets / (liabilities) 37,351.26
Total assets less current liabilities 37,351.26
Accruals and deferred income (550.00)
Net assets 36,801.26
Capital and reserves 36,801.26

For the period from 27 January 2025 to 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Vinoda Rao Nelluri
23 October 2026

Notes to the accounts

  1. Average number of employees

    During the period the average number of employees was 2.